Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Vessel Prosthesis Implantation | 32 | 2024 | 1390 | 8.030 |
Why?
|
Peripheral Arterial Disease | 27 | 2023 | 1188 | 8.020 |
Why?
|
Endovascular Procedures | 50 | 2024 | 1979 | 7.490 |
Why?
|
Vascular Surgical Procedures | 27 | 2022 | 1475 | 6.240 |
Why?
|
Vascular System Injuries | 12 | 2022 | 250 | 4.300 |
Why?
|
Ischemia | 20 | 2023 | 1914 | 4.110 |
Why?
|
Aortic Aneurysm, Abdominal | 19 | 2024 | 1186 | 3.970 |
Why?
|
Popliteal Artery | 12 | 2023 | 317 | 3.770 |
Why?
|
Lower Extremity | 17 | 2023 | 1158 | 3.570 |
Why?
|
Limb Salvage | 21 | 2023 | 433 | 3.450 |
Why?
|
Vascular Grafting | 7 | 2023 | 142 | 3.390 |
Why?
|
Venous Insufficiency | 5 | 2021 | 103 | 2.890 |
Why?
|
Graft Occlusion, Vascular | 6 | 2023 | 549 | 2.690 |
Why?
|
Femoral Artery | 8 | 2022 | 845 | 2.660 |
Why?
|
Endarterectomy, Carotid | 9 | 2023 | 546 | 2.640 |
Why?
|
Aortic Diseases | 5 | 2023 | 742 | 2.320 |
Why?
|
Vascular Patency | 16 | 2023 | 886 | 2.120 |
Why?
|
Carotid Stenosis | 6 | 2023 | 854 | 2.090 |
Why?
|
Venous Thrombosis | 10 | 2020 | 1238 | 2.060 |
Why?
|
Aortic Aneurysm, Thoracic | 9 | 2023 | 686 | 2.010 |
Why?
|
Blood Vessel Prosthesis | 8 | 2022 | 933 | 2.000 |
Why?
|
Thrombosis | 6 | 2023 | 2968 | 1.950 |
Why?
|
Treatment Outcome | 96 | 2024 | 63119 | 1.930 |
Why?
|
Iliac Vein | 3 | 2019 | 72 | 1.760 |
Why?
|
Thrombelastography | 3 | 2022 | 163 | 1.650 |
Why?
|
Ulcer | 3 | 2023 | 209 | 1.640 |
Why?
|
Time Factors | 55 | 2022 | 40063 | 1.610 |
Why?
|
Risk Factors | 81 | 2024 | 72280 | 1.610 |
Why?
|
Venous Thromboembolism | 6 | 2023 | 1670 | 1.590 |
Why?
|
Thrombophlebitis | 3 | 2019 | 309 | 1.560 |
Why?
|
Angioplasty | 3 | 2019 | 364 | 1.550 |
Why?
|
Retrospective Studies | 86 | 2024 | 77426 | 1.490 |
Why?
|
Aneurysm, Infected | 4 | 2021 | 85 | 1.460 |
Why?
|
Aneurysm | 3 | 2023 | 339 | 1.460 |
Why?
|
Ultrasonography, Doppler | 3 | 2023 | 458 | 1.430 |
Why?
|
Aortic Rupture | 6 | 2022 | 310 | 1.420 |
Why?
|
Databases, Factual | 27 | 2021 | 7730 | 1.410 |
Why?
|
Femoral Vein | 3 | 2020 | 159 | 1.400 |
Why?
|
Thoracic Outlet Syndrome | 3 | 2020 | 86 | 1.390 |
Why?
|
Ribs | 3 | 2020 | 252 | 1.370 |
Why?
|
Stents | 15 | 2022 | 3280 | 1.300 |
Why?
|
Aneurysm, False | 4 | 2022 | 276 | 1.290 |
Why?
|
Surgical Wound Infection | 5 | 2020 | 1540 | 1.280 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2023 | 277 | 1.250 |
Why?
|
Pregnancy Complications, Cardiovascular | 3 | 2022 | 501 | 1.240 |
Why?
|
Ultrasonography, Doppler, Duplex | 2 | 2021 | 205 | 1.210 |
Why?
|
Decompression, Surgical | 4 | 2020 | 594 | 1.200 |
Why?
|
Varicose Veins | 2 | 2022 | 154 | 1.110 |
Why?
|
Osteotomy | 3 | 2020 | 822 | 1.040 |
Why?
|
Education, Medical, Graduate | 7 | 2021 | 2291 | 1.000 |
Why?
|
Quality Indicators, Health Care | 4 | 2021 | 1831 | 0.990 |
Why?
|
Humans | 162 | 2024 | 744220 | 0.970 |
Why?
|
Carotid Artery Diseases | 5 | 2017 | 882 | 0.970 |
Why?
|
Intermittent Claudication | 3 | 2023 | 309 | 0.960 |
Why?
|
Prosthesis-Related Infections | 2 | 2021 | 538 | 0.930 |
Why?
|
Specialties, Surgical | 2 | 2022 | 391 | 0.920 |
Why?
|
Saphenous Vein | 3 | 2021 | 532 | 0.920 |
Why?
|
Veins | 3 | 2023 | 769 | 0.910 |
Why?
|
Aorta, Thoracic | 3 | 2022 | 1082 | 0.910 |
Why?
|
Renal Dialysis | 4 | 2020 | 1787 | 0.890 |
Why?
|
Patient Readmission | 4 | 2022 | 3114 | 0.880 |
Why?
|
Vascular Diseases | 2 | 2021 | 1161 | 0.860 |
Why?
|
Leg Injuries | 2 | 2014 | 178 | 0.840 |
Why?
|
Postoperative Complications | 21 | 2023 | 15294 | 0.840 |
Why?
|
Gangrene | 1 | 2022 | 82 | 0.820 |
Why?
|
Pre-Eclampsia | 2 | 2022 | 1200 | 0.810 |
Why?
|
Platelet Aggregation Inhibitors | 6 | 2023 | 3068 | 0.800 |
Why?
|
Aorta, Abdominal | 2 | 2021 | 645 | 0.800 |
Why?
|
United States | 40 | 2023 | 69867 | 0.800 |
Why?
|
Wounds, Nonpenetrating | 4 | 2022 | 794 | 0.790 |
Why?
|
Practice Guidelines as Topic | 6 | 2021 | 7281 | 0.780 |
Why?
|
Skin Diseases, Viral | 1 | 2020 | 21 | 0.760 |
Why?
|
Negative-Pressure Wound Therapy | 2 | 2020 | 150 | 0.750 |
Why?
|
Aged | 60 | 2023 | 163253 | 0.750 |
Why?
|
Spinal Cord Ischemia | 1 | 2021 | 93 | 0.740 |
Why?
|
Wound Infection | 1 | 2022 | 242 | 0.740 |
Why?
|
Risk Assessment | 23 | 2023 | 23337 | 0.730 |
Why?
|
Atherosclerosis | 3 | 2023 | 3444 | 0.720 |
Why?
|
Endarterectomy | 1 | 2020 | 195 | 0.720 |
Why?
|
Therapeutics | 1 | 2020 | 116 | 0.720 |
Why?
|
Specialization | 2 | 2016 | 777 | 0.720 |
Why?
|
Puerperal Disorders | 1 | 2022 | 275 | 0.710 |
Why?
|
Renal Artery | 3 | 2021 | 398 | 0.710 |
Why?
|
Female | 89 | 2023 | 380197 | 0.710 |
Why?
|
Male | 86 | 2023 | 350027 | 0.700 |
Why?
|
Toes | 1 | 2020 | 207 | 0.690 |
Why?
|
Partnership Practice | 1 | 2018 | 16 | 0.680 |
Why?
|
Arthroplasty, Replacement, Knee | 3 | 2016 | 1458 | 0.670 |
Why?
|
Pressure Ulcer | 1 | 2020 | 155 | 0.670 |
Why?
|
Blood Group Antigens | 1 | 2020 | 180 | 0.660 |
Why?
|
Health Care Costs | 5 | 2021 | 3209 | 0.660 |
Why?
|
Peripheral Vascular Diseases | 2 | 2019 | 550 | 0.650 |
Why?
|
Physicians, Women | 2 | 2021 | 486 | 0.640 |
Why?
|
Blood Coagulation | 2 | 2021 | 1127 | 0.630 |
Why?
|
Brachial Artery | 2 | 2019 | 370 | 0.630 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3132 | 0.630 |
Why?
|
Radial Artery | 2 | 2019 | 194 | 0.630 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3239 | 0.620 |
Why?
|
Anticoagulants | 8 | 2023 | 4599 | 0.620 |
Why?
|
Professional Practice | 1 | 2020 | 326 | 0.620 |
Why?
|
Public-Private Sector Partnerships | 1 | 2019 | 121 | 0.620 |
Why?
|
Groin | 1 | 2018 | 103 | 0.620 |
Why?
|
Hospital Costs | 4 | 2017 | 984 | 0.620 |
Why?
|
Middle Aged | 57 | 2023 | 213367 | 0.610 |
Why?
|
Bibliometrics | 1 | 2021 | 339 | 0.610 |
Why?
|
Interinstitutional Relations | 1 | 2019 | 240 | 0.610 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 252 | 0.600 |
Why?
|
Aged, 80 and over | 25 | 2023 | 57768 | 0.600 |
Why?
|
Asymptomatic Diseases | 5 | 2020 | 552 | 0.590 |
Why?
|
Kidney Failure, Chronic | 2 | 2020 | 2538 | 0.590 |
Why?
|
Insurance Benefits | 1 | 2018 | 183 | 0.580 |
Why?
|
Health Care Sector | 1 | 2019 | 194 | 0.580 |
Why?
|
Upper Extremity | 2 | 2019 | 648 | 0.580 |
Why?
|
Postoperative Hemorrhage | 2 | 2021 | 412 | 0.580 |
Why?
|
Leg | 2 | 2023 | 1117 | 0.570 |
Why?
|
Collateral Circulation | 3 | 2021 | 287 | 0.570 |
Why?
|
Bacteremia | 2 | 2021 | 962 | 0.570 |
Why?
|
Thrombolytic Therapy | 4 | 2019 | 2161 | 0.560 |
Why?
|
Internship and Residency | 4 | 2021 | 5787 | 0.560 |
Why?
|
Physician Incentive Plans | 1 | 2017 | 161 | 0.560 |
Why?
|
Thoracic Injuries | 2 | 2022 | 272 | 0.550 |
Why?
|
Gait | 1 | 2021 | 793 | 0.550 |
Why?
|
Dyslipidemias | 1 | 2023 | 849 | 0.550 |
Why?
|
Foot | 1 | 2019 | 528 | 0.550 |
Why?
|
Hospital Mortality | 10 | 2023 | 5316 | 0.540 |
Why?
|
Quality of Life | 4 | 2022 | 12805 | 0.540 |
Why?
|
Fibrinolytic Agents | 3 | 2023 | 2158 | 0.530 |
Why?
|
Chi-Square Distribution | 8 | 2016 | 3509 | 0.530 |
Why?
|
Popliteal Vein | 1 | 2015 | 43 | 0.520 |
Why?
|
Length of Stay | 15 | 2023 | 6308 | 0.520 |
Why?
|
Value of Life | 1 | 2015 | 97 | 0.510 |
Why?
|
Motorcycles | 1 | 2015 | 44 | 0.510 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2019 | 846 | 0.510 |
Why?
|
Monitoring, Intraoperative | 1 | 2021 | 953 | 0.510 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.510 |
Why?
|
Surgery, Plastic | 1 | 2021 | 624 | 0.500 |
Why?
|
Hospitalization | 4 | 2020 | 10262 | 0.500 |
Why?
|
Substance Abuse, Intravenous | 2 | 2021 | 525 | 0.490 |
Why?
|
Critical Illness | 8 | 2021 | 2670 | 0.490 |
Why?
|
Hematoma | 4 | 2023 | 758 | 0.490 |
Why?
|
Walking | 1 | 2021 | 1180 | 0.480 |
Why?
|
Military Medicine | 2 | 2013 | 176 | 0.480 |
Why?
|
Patient Care | 1 | 2020 | 640 | 0.480 |
Why?
|
Varicose Ulcer | 1 | 2014 | 52 | 0.480 |
Why?
|
Head Protective Devices | 1 | 2015 | 114 | 0.480 |
Why?
|
Benchmarking | 1 | 2020 | 1042 | 0.470 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 6489 | 0.470 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2016 | 1462 | 0.460 |
Why?
|
Renal Artery Obstruction | 1 | 2015 | 248 | 0.460 |
Why?
|
Chronic Disease | 7 | 2023 | 9147 | 0.460 |
Why?
|
Occupational Exposure | 2 | 2021 | 1796 | 0.450 |
Why?
|
Pacemaker, Artificial | 1 | 2019 | 818 | 0.450 |
Why?
|
Hospitals, Military | 1 | 2013 | 67 | 0.450 |
Why?
|
Hospitals, Teaching | 2 | 2016 | 1179 | 0.440 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 1451 | 0.440 |
Why?
|
Medically Uninsured | 1 | 2018 | 853 | 0.440 |
Why?
|
Prosthesis Design | 7 | 2023 | 2110 | 0.430 |
Why?
|
Celiac Artery | 2 | 2022 | 69 | 0.430 |
Why?
|
Cholecystitis | 1 | 2013 | 182 | 0.430 |
Why?
|
Exercise Therapy | 1 | 2019 | 906 | 0.430 |
Why?
|
Carotid Artery Injuries | 1 | 2013 | 96 | 0.430 |
Why?
|
Incidence | 14 | 2022 | 20945 | 0.430 |
Why?
|
Aneurysm, Ruptured | 2 | 2014 | 452 | 0.420 |
Why?
|
Reimbursement, Incentive | 1 | 2017 | 540 | 0.420 |
Why?
|
General Surgery | 3 | 2021 | 1636 | 0.420 |
Why?
|
Polytetrafluoroethylene | 3 | 2022 | 233 | 0.420 |
Why?
|
Specialty Boards | 1 | 2014 | 227 | 0.420 |
Why?
|
Salvage Therapy | 1 | 2019 | 1275 | 0.420 |
Why?
|
Wound Healing | 6 | 2023 | 2785 | 0.420 |
Why?
|
Jugular Veins | 1 | 2013 | 204 | 0.410 |
Why?
|
Staphylococcal Infections | 1 | 2021 | 1400 | 0.410 |
Why?
|
Decision Support Techniques | 3 | 2021 | 1955 | 0.410 |
Why?
|
Neck Dissection | 1 | 2013 | 197 | 0.410 |
Why?
|
Injury Severity Score | 5 | 2015 | 1013 | 0.400 |
Why?
|
Stroke | 7 | 2022 | 9981 | 0.400 |
Why?
|
Sex Factors | 10 | 2021 | 10396 | 0.400 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1519 | 0.390 |
Why?
|
Altruism | 1 | 2013 | 204 | 0.390 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 547 | 0.390 |
Why?
|
Registries | 10 | 2021 | 8090 | 0.380 |
Why?
|
Prospective Studies | 13 | 2023 | 53280 | 0.380 |
Why?
|
Carotid Artery, Internal | 1 | 2013 | 445 | 0.380 |
Why?
|
Rectal Neoplasms | 1 | 2020 | 1203 | 0.370 |
Why?
|
Quality Improvement | 6 | 2023 | 3746 | 0.370 |
Why?
|
Wounds, Gunshot | 2 | 2013 | 563 | 0.370 |
Why?
|
Health Status Disparities | 3 | 2016 | 1797 | 0.370 |
Why?
|
Calcium | 1 | 2023 | 5757 | 0.370 |
Why?
|
Laparoscopy | 1 | 2022 | 2149 | 0.370 |
Why?
|
Multivariate Analysis | 9 | 2016 | 12244 | 0.370 |
Why?
|
Watchful Waiting | 1 | 2014 | 491 | 0.360 |
Why?
|
Pandemics | 5 | 2021 | 8387 | 0.360 |
Why?
|
Adult | 34 | 2023 | 214035 | 0.360 |
Why?
|
Wounds and Injuries | 2 | 2020 | 2400 | 0.350 |
Why?
|
Healthcare Disparities | 4 | 2021 | 3158 | 0.350 |
Why?
|
Blast Injuries | 1 | 2013 | 302 | 0.350 |
Why?
|
Accidents, Traffic | 1 | 2015 | 819 | 0.350 |
Why?
|
Hospital Charges | 3 | 2016 | 362 | 0.340 |
Why?
|
Odds Ratio | 7 | 2017 | 9849 | 0.340 |
Why?
|
Age Factors | 9 | 2021 | 18367 | 0.340 |
Why?
|
Resuscitation | 2 | 2014 | 657 | 0.330 |
Why?
|
Uncertainty | 1 | 2014 | 734 | 0.330 |
Why?
|
Tibia | 1 | 2014 | 1077 | 0.330 |
Why?
|
Clinical Competence | 4 | 2022 | 4687 | 0.320 |
Why?
|
Cost Savings | 3 | 2021 | 926 | 0.320 |
Why?
|
Spinal Diseases | 1 | 2013 | 538 | 0.320 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3256 | 0.310 |
Why?
|
Hypertension | 3 | 2023 | 8480 | 0.310 |
Why?
|
Physicians, Primary Care | 1 | 2014 | 591 | 0.310 |
Why?
|
Sclerotherapy | 2 | 2021 | 175 | 0.300 |
Why?
|
Comorbidity | 6 | 2021 | 10387 | 0.300 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5755 | 0.300 |
Why?
|
Pulmonary Embolism | 4 | 2020 | 2375 | 0.300 |
Why?
|
Insurance Coverage | 1 | 2018 | 1901 | 0.290 |
Why?
|
Health Personnel | 1 | 2020 | 3216 | 0.290 |
Why?
|
Heart Diseases | 2 | 2019 | 2790 | 0.280 |
Why?
|
Recovery of Function | 4 | 2020 | 2925 | 0.280 |
Why?
|
Hospital Bed Capacity | 2 | 2020 | 214 | 0.280 |
Why?
|
Cerebrovascular Disorders | 1 | 2013 | 1504 | 0.280 |
Why?
|
Insurance, Health | 1 | 2018 | 2494 | 0.270 |
Why?
|
Angiography | 3 | 2023 | 1638 | 0.270 |
Why?
|
Endoleak | 3 | 2024 | 106 | 0.270 |
Why?
|
Tuberculosis, Cardiovascular | 2 | 2016 | 9 | 0.270 |
Why?
|
Blood Transfusion | 3 | 2021 | 1296 | 0.270 |
Why?
|
Algorithms | 4 | 2021 | 13885 | 0.270 |
Why?
|
Ligation | 2 | 2017 | 453 | 0.260 |
Why?
|
Young Adult | 17 | 2021 | 56436 | 0.260 |
Why?
|
Medicaid | 1 | 2018 | 2736 | 0.260 |
Why?
|
Abdominal Pain | 2 | 2022 | 1062 | 0.260 |
Why?
|
Reoperation | 6 | 2019 | 4203 | 0.260 |
Why?
|
Postpartum Period | 2 | 2022 | 1086 | 0.260 |
Why?
|
Logistic Models | 6 | 2017 | 13409 | 0.250 |
Why?
|
Military Personnel | 1 | 2014 | 1133 | 0.250 |
Why?
|
Health Care Surveys | 3 | 2020 | 2453 | 0.250 |
Why?
|
Thoracic Surgery | 2 | 2022 | 719 | 0.240 |
Why?
|
Medicare | 2 | 2019 | 6566 | 0.240 |
Why?
|
Anti-Bacterial Agents | 5 | 2018 | 7179 | 0.240 |
Why?
|
Lumbar Vertebrae | 1 | 2013 | 1848 | 0.230 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15070 | 0.230 |
Why?
|
Anemia | 2 | 2023 | 1504 | 0.230 |
Why?
|
Catheter Ablation | 1 | 2016 | 2758 | 0.230 |
Why?
|
Aortography | 2 | 2024 | 437 | 0.220 |
Why?
|
Cost-Benefit Analysis | 4 | 2016 | 5396 | 0.220 |
Why?
|
Prognosis | 6 | 2021 | 29050 | 0.220 |
Why?
|
Orthopedic Procedures | 1 | 2013 | 1288 | 0.220 |
Why?
|
Phantom Limb | 1 | 2024 | 91 | 0.210 |
Why?
|
Factor Xa | 1 | 2023 | 162 | 0.210 |
Why?
|
Urinary Retention | 1 | 2023 | 111 | 0.210 |
Why?
|
BCG Vaccine | 2 | 2016 | 368 | 0.210 |
Why?
|
Disability Evaluation | 2 | 2020 | 1828 | 0.210 |
Why?
|
Ligaments | 1 | 2022 | 128 | 0.210 |
Why?
|
Adolescent | 15 | 2020 | 85759 | 0.210 |
Why?
|
Afghan Campaign 2001- | 2 | 2014 | 272 | 0.210 |
Why?
|
Neurosurgical Procedures | 1 | 2013 | 2003 | 0.200 |
Why?
|
Patient Care Team | 1 | 2013 | 2529 | 0.200 |
Why?
|
Phlebography | 2 | 2020 | 333 | 0.200 |
Why?
|
Splenic Artery | 1 | 2021 | 54 | 0.200 |
Why?
|
Prevalence | 6 | 2021 | 15226 | 0.200 |
Why?
|
Mesenteric Arteries | 1 | 2021 | 183 | 0.200 |
Why?
|
Biomedical Research | 1 | 2017 | 3311 | 0.200 |
Why?
|
Radiography, Interventional | 2 | 2021 | 1095 | 0.190 |
Why?
|
Thrombin | 1 | 2023 | 598 | 0.190 |
Why?
|
Patient Selection | 4 | 2018 | 4216 | 0.190 |
Why?
|
Remission, Spontaneous | 1 | 2021 | 380 | 0.190 |
Why?
|
Aspirin | 2 | 2023 | 3282 | 0.190 |
Why?
|
Hospitals | 1 | 2014 | 3952 | 0.190 |
Why?
|
Platelet Function Tests | 1 | 2022 | 270 | 0.190 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1971 | 0.190 |
Why?
|
Vena Cava, Inferior | 2 | 2013 | 436 | 0.190 |
Why?
|
Absorbable Implants | 1 | 2023 | 342 | 0.190 |
Why?
|
Pregnancy | 6 | 2022 | 29142 | 0.180 |
Why?
|
Disease Progression | 5 | 2022 | 13280 | 0.180 |
Why?
|
Ultrasonography | 2 | 2023 | 5982 | 0.180 |
Why?
|
Tibial Arteries | 1 | 2019 | 57 | 0.180 |
Why?
|
Standard of Care | 1 | 2023 | 564 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 2 | 2022 | 6535 | 0.170 |
Why?
|
Splenectomy | 1 | 2021 | 395 | 0.170 |
Why?
|
Platelet Aggregation | 1 | 2022 | 800 | 0.170 |
Why?
|
Models, Statistical | 1 | 2014 | 5102 | 0.170 |
Why?
|
Budgets | 1 | 2021 | 229 | 0.170 |
Why?
|
Arm Injuries | 1 | 2021 | 160 | 0.170 |
Why?
|
Hemothorax | 1 | 2019 | 59 | 0.170 |
Why?
|
Cooperative Behavior | 2 | 2019 | 1504 | 0.170 |
Why?
|
Constriction, Pathologic | 2 | 2020 | 1107 | 0.170 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15538 | 0.170 |
Why?
|
Coated Materials, Biocompatible | 1 | 2021 | 319 | 0.170 |
Why?
|
Carotid Arteries | 1 | 2023 | 952 | 0.160 |
Why?
|
Primary Health Care | 1 | 2014 | 4556 | 0.160 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2019 | 89 | 0.160 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15161 | 0.150 |
Why?
|
Ticlopidine | 1 | 2023 | 899 | 0.150 |
Why?
|
Blood Loss, Surgical | 1 | 2021 | 661 | 0.150 |
Why?
|
Body Mass Index | 1 | 2015 | 12718 | 0.150 |
Why?
|
Hypotension | 1 | 2023 | 880 | 0.150 |
Why?
|
Vasculitis | 1 | 2021 | 521 | 0.150 |
Why?
|
Efficiency, Organizational | 1 | 2021 | 695 | 0.140 |
Why?
|
Cross-Sectional Studies | 8 | 2019 | 25043 | 0.140 |
Why?
|
Treatment Failure | 1 | 2022 | 2619 | 0.140 |
Why?
|
Florida | 1 | 2017 | 435 | 0.140 |
Why?
|
Metals | 1 | 2021 | 719 | 0.140 |
Why?
|
Mentors | 1 | 2021 | 630 | 0.140 |
Why?
|
Phenazines | 1 | 2016 | 58 | 0.140 |
Why?
|
Gentian Violet | 1 | 2016 | 31 | 0.140 |
Why?
|
Texas | 2 | 2014 | 392 | 0.140 |
Why?
|
Mycobacterium bovis | 1 | 2016 | 150 | 0.130 |
Why?
|
Scotland | 2 | 2012 | 155 | 0.130 |
Why?
|
Molecular Typing | 1 | 2016 | 106 | 0.130 |
Why?
|
Regional Blood Flow | 2 | 2021 | 1525 | 0.130 |
Why?
|
Night Care | 1 | 2015 | 28 | 0.130 |
Why?
|
Aorta | 1 | 2023 | 2061 | 0.130 |
Why?
|
Live Birth | 1 | 2019 | 512 | 0.130 |
Why?
|
Pneumothorax | 1 | 2019 | 379 | 0.130 |
Why?
|
Learning Curve | 1 | 2016 | 208 | 0.130 |
Why?
|
Pregnancy Trimester, First | 1 | 2019 | 853 | 0.130 |
Why?
|
Stockings, Compression | 1 | 2014 | 37 | 0.130 |
Why?
|
Arterial Occlusive Diseases | 1 | 2019 | 793 | 0.130 |
Why?
|
Neoplasms | 2 | 2021 | 21672 | 0.120 |
Why?
|
Hypothyroidism | 1 | 2020 | 659 | 0.120 |
Why?
|
Computer Simulation | 2 | 2022 | 6196 | 0.120 |
Why?
|
Operating Rooms | 1 | 2021 | 815 | 0.120 |
Why?
|
Discriminant Analysis | 1 | 2014 | 235 | 0.120 |
Why?
|
Curriculum | 2 | 2019 | 3604 | 0.120 |
Why?
|
Tuberculoma | 1 | 2013 | 14 | 0.120 |
Why?
|
Research Support as Topic | 1 | 2019 | 704 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1462 | 0.120 |
Why?
|
Magnetic Resonance Angiography | 1 | 2021 | 1442 | 0.120 |
Why?
|
Catheterization, Peripheral | 1 | 2018 | 344 | 0.120 |
Why?
|
Shock, Traumatic | 1 | 2013 | 22 | 0.120 |
Why?
|
Baltimore | 1 | 2014 | 231 | 0.120 |
Why?
|
Medical Informatics | 1 | 2021 | 743 | 0.120 |
Why?
|
Minority Groups | 1 | 2021 | 1223 | 0.120 |
Why?
|
Blood Preservation | 1 | 2014 | 177 | 0.110 |
Why?
|
Debridement | 1 | 2016 | 492 | 0.110 |
Why?
|
Wisconsin | 1 | 2013 | 124 | 0.110 |
Why?
|
Cecal Diseases | 1 | 2013 | 51 | 0.110 |
Why?
|
Propensity Score | 2 | 2020 | 1781 | 0.110 |
Why?
|
Iraq | 1 | 2013 | 92 | 0.110 |
Why?
|
Portal Vein | 1 | 2016 | 437 | 0.110 |
Why?
|
Hip Joint | 1 | 2020 | 1002 | 0.110 |
Why?
|
Renal Insufficiency | 1 | 2019 | 804 | 0.110 |
Why?
|
Cost of Illness | 2 | 2021 | 1859 | 0.110 |
Why?
|
Second-Look Surgery | 1 | 2012 | 29 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 6 | 2015 | 20123 | 0.110 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2015 | 426 | 0.110 |
Why?
|
Drug Utilization Review | 1 | 2013 | 245 | 0.110 |
Why?
|
Critical Pathways | 1 | 2016 | 476 | 0.110 |
Why?
|
Appendix | 1 | 2013 | 110 | 0.100 |
Why?
|
Drug Therapy, Combination | 1 | 2022 | 6485 | 0.100 |
Why?
|
Blood Platelets | 1 | 2022 | 2508 | 0.100 |
Why?
|
Ownership | 1 | 2014 | 332 | 0.100 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5138 | 0.100 |
Why?
|
Inservice Training | 1 | 2014 | 392 | 0.100 |
Why?
|
Athletes | 1 | 2019 | 1093 | 0.100 |
Why?
|
Weight Gain | 1 | 2022 | 2292 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2016 | 1100 | 0.100 |
Why?
|
Diffusion of Innovation | 1 | 2016 | 725 | 0.100 |
Why?
|
Thymoma | 1 | 2013 | 186 | 0.100 |
Why?
|
Cholecystectomy | 1 | 2013 | 395 | 0.100 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2013 | 254 | 0.100 |
Why?
|
Attitude to Computers | 1 | 2012 | 202 | 0.100 |
Why?
|
Ultrasonography, Prenatal | 1 | 2019 | 1695 | 0.100 |
Why?
|
Multiple Trauma | 1 | 2014 | 367 | 0.100 |
Why?
|
International Normalized Ratio | 1 | 2012 | 367 | 0.100 |
Why?
|
Plasma | 1 | 2014 | 575 | 0.100 |
Why?
|
Shock, Hemorrhagic | 1 | 2012 | 220 | 0.100 |
Why?
|
Antitubercular Agents | 2 | 2016 | 1320 | 0.100 |
Why?
|
Boston | 2 | 2021 | 9311 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1483 | 0.090 |
Why?
|
Program Evaluation | 2 | 2021 | 2486 | 0.090 |
Why?
|
Models, Economic | 1 | 2015 | 713 | 0.090 |
Why?
|
Glasgow Coma Scale | 1 | 2012 | 570 | 0.090 |
Why?
|
Skin Transplantation | 1 | 2016 | 1074 | 0.090 |
Why?
|
Activities of Daily Living | 1 | 2020 | 2420 | 0.090 |
Why?
|
Capillary Permeability | 1 | 2014 | 798 | 0.090 |
Why?
|
Life Style | 1 | 2022 | 3835 | 0.090 |
Why?
|
Thymus Neoplasms | 1 | 2013 | 268 | 0.090 |
Why?
|
Abdominal Injuries | 1 | 2013 | 352 | 0.090 |
Why?
|
Area Under Curve | 1 | 2014 | 1655 | 0.090 |
Why?
|
Arteriovenous Fistula | 1 | 2013 | 315 | 0.090 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 934 | 0.090 |
Why?
|
Endocarditis, Bacterial | 1 | 2014 | 455 | 0.090 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2796 | 0.090 |
Why?
|
Consensus | 2 | 2023 | 2958 | 0.090 |
Why?
|
Computer Communication Networks | 1 | 2012 | 295 | 0.090 |
Why?
|
Age Distribution | 1 | 2016 | 2903 | 0.090 |
Why?
|
Anastomosis, Surgical | 1 | 2013 | 987 | 0.090 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2018 | 1209 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8628 | 0.080 |
Why?
|
Hyperlipidemias | 1 | 2013 | 788 | 0.080 |
Why?
|
Canada | 1 | 2013 | 2065 | 0.080 |
Why?
|
Sex Distribution | 1 | 2013 | 2297 | 0.080 |
Why?
|
Child, Preschool | 4 | 2019 | 40992 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39045 | 0.080 |
Why?
|
Thromboembolism | 1 | 2014 | 985 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3063 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3778 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3395 | 0.080 |
Why?
|
Recurrence | 2 | 2016 | 8343 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 950 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7784 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3527 | 0.070 |
Why?
|
Patient Admission | 1 | 2014 | 1380 | 0.070 |
Why?
|
Triage | 1 | 2013 | 976 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6172 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2016 | 2237 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12961 | 0.070 |
Why?
|
Surgical Flaps | 1 | 2014 | 1640 | 0.070 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3674 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4929 | 0.070 |
Why?
|
Administration, Intravesical | 2 | 2016 | 91 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3313 | 0.060 |
Why?
|
Endometriosis | 1 | 2013 | 839 | 0.060 |
Why?
|
Punctures | 2 | 2018 | 374 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6893 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13990 | 0.060 |
Why?
|
Pulmonary Artery | 1 | 2013 | 1912 | 0.060 |
Why?
|
Outpatients | 1 | 2012 | 1486 | 0.060 |
Why?
|
Intensive Care Units | 2 | 2014 | 3680 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2014 | 2266 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 4935 | 0.060 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1392 | 0.060 |
Why?
|
Child | 5 | 2019 | 77679 | 0.060 |
Why?
|
Nova Scotia | 1 | 2022 | 34 | 0.060 |
Why?
|
Leg Ulcer | 1 | 2023 | 69 | 0.050 |
Why?
|
Subclavian Artery | 1 | 2022 | 129 | 0.050 |
Why?
|
Intercostal Nerves | 1 | 2022 | 26 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10250 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13668 | 0.050 |
Why?
|
Anesthesia, Local | 1 | 2024 | 273 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2013 | 1916 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3528 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2014 | 3478 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2021 | 20817 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19907 | 0.040 |
Why?
|
Survival Rate | 1 | 2014 | 12781 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2014 | 2425 | 0.040 |
Why?
|
Plethysmography | 1 | 2019 | 180 | 0.040 |
Why?
|
Collagen Type III | 1 | 2019 | 90 | 0.040 |
Why?
|
Health Plan Implementation | 1 | 2021 | 351 | 0.040 |
Why?
|
Axillary Artery | 1 | 2018 | 50 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1119 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.040 |
Why?
|
Communication | 1 | 2012 | 3749 | 0.040 |
Why?
|
Arm | 1 | 2021 | 590 | 0.040 |
Why?
|
Morphine | 1 | 2022 | 657 | 0.040 |
Why?
|
Retreatment | 1 | 2019 | 610 | 0.040 |
Why?
|
Catheterization | 1 | 2023 | 1469 | 0.040 |
Why?
|
Patient Positioning | 1 | 2020 | 323 | 0.040 |
Why?
|
Foreign-Body Migration | 1 | 2019 | 221 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2021 | 924 | 0.040 |
Why?
|
Hemodynamics | 2 | 2020 | 4199 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1533 | 0.040 |
Why?
|
Workflow | 1 | 2021 | 847 | 0.040 |
Why?
|
Cadaver | 1 | 2020 | 1337 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1769 | 0.030 |
Why?
|
Liver Circulation | 1 | 2016 | 163 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 10905 | 0.030 |
Why?
|
California | 1 | 2019 | 1402 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2309 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2047 | 0.030 |
Why?
|
Range of Motion, Articular | 1 | 2020 | 1579 | 0.030 |
Why?
|
Vital Signs | 1 | 2013 | 141 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1640 | 0.030 |
Why?
|
Hemostasis | 1 | 2014 | 458 | 0.020 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2015 | 501 | 0.020 |
Why?
|
Work Schedule Tolerance | 1 | 2015 | 565 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2759 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7148 | 0.020 |
Why?
|
Electronic Mail | 1 | 2012 | 213 | 0.020 |
Why?
|
Cardiology Service, Hospital | 1 | 2012 | 246 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2569 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2702 | 0.020 |
Why?
|
Workload | 1 | 2015 | 850 | 0.020 |
Why?
|
Angioplasty, Balloon | 1 | 2013 | 653 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
Trauma Centers | 1 | 2013 | 889 | 0.020 |
Why?
|
Tissue Donors | 1 | 2016 | 2242 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3443 | 0.020 |
Why?
|
Linear Models | 1 | 2013 | 5953 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4419 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 7022 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4455 | 0.010 |
Why?
|
Biopsy | 1 | 2013 | 6757 | 0.010 |
Why?
|
Rural Population | 1 | 2012 | 2210 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3842 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10634 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14726 | 0.010 |
Why?
|
Brain | 1 | 2024 | 26413 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35129 | 0.010 |
Why?
|
Telemedicine | 1 | 2012 | 2872 | 0.010 |
Why?
|